Pharma marketers have become sophisticated at reaching prescribers. The targeting is more precise, the channels more measurable, and the creative more tailored than ever before. And yet, for many brands, a critical audience remains largely unaddressed in the media plan: the managed care professionals who determine whether a prescribed therapy is actually accessible to the patients who need it.
This isn’t a niche consideration. Formulary decisions, prior authorization criteria, step therapy requirements, and tiering structures are among the most consequential forces acting on any brand’s real-world performance. A prescriber can be fully convinced and still write a script that never gets filled. Understanding who makes those access decisions and how to reach them is as important to brand performance as any HCP or patient campaign.
Who Makes Managed Care Decisions
The managed care audience is broader than many marketers assume. It includes pharmacy directors, medical directors, and P&T committee members at commercial health plans and PBMs. It includes formulary analysts and market access leaders at integrated delivery networks and health systems. It includes the managed care pharmacists and clinical consultants who evaluate new therapies against existing options and build the criteria that govern patient access.
These professionals are specialists. They evaluate brands differently than prescribers do, through the lens of comparative effectiveness, total cost of care, budget impact, and population-level outcomes. Reaching them requires dedicated strategy, not a spillover from your HCP targeting.
What They Need to Hear
Managed care audiences are not persuaded by the same messaging that moves prescribers. Clinical differentiation matters, but it needs to be translated into the language of value: what does this therapy mean for outcomes in their specific patient population, what does it do to downstream utilization, and how does it compare to what they’re already covering?
This is where many pharma media plans fall short. The value story for payers often lives in AMCP dossiers and formulary presentations, not in the ambient media environment where managed care professionals are consuming information every day. The gap between what brand teams know about payer value and what actually reaches payer audiences through media is significant, and largely unnecessary.
The Case for Dedicated Managed Care Media Investment
Managed care professionals read. They follow industry news, clinical developments, and policy changes with the same attentiveness as the physicians in their networks. Daily news briefings, specialty publications, and professional association communications are part of how they stay current, and they are receptive to well-placed, relevant advertising in those environments.
The argument for including managed care audiences in your media plan is straightforward. These are the decision-makers who translate clinical performance into access policy. Reaching them with the right value message, in a credible professional context, at the right point in a formulary review cycle, can meaningfully affect brand access. Not reaching them leaves that influence to chance.
For brands with managed care objectives such as formulary placement, preferred tier status, and PA criteria management, media investment that specifically targets this audience is a logical and often underutilized complement to field account team activity. It builds awareness and credibility with decision-makers before the sales conversation happens, and it reinforces the value story in between those touchpoints.
A Practical Note on Reach
One reason managed care media investment has historically been underutilized is a perception that this audience is too small or too diffuse to reach efficiently. In practice, that’s less true than it used to be. Purpose-built managed care media programs, including those through professional associations like the Academy of Managed Care Pharmacy, offer direct, verified access to the formulary decision-makers who matter most to brand performance. The audience may be smaller than a broad HCP campaign, but the leverage each individual in that audience has over real-world access makes the investment case compelling.
BulletinHealthcare’s managed care programs through our partnership with AMCP are designed specifically for this purpose: reaching the right managed care professionals in a high-engagement, endemic environment, with messaging that is relevant to how they evaluate and make coverage decisions.
Ready to talk? Reach out to us today!
